Health
Moderna’s COVID-19 vaccine candidate moves into late-stage trial – The Indian Express
Moderna said it remains on track to deliver about 500 million doses a year, and possibly up to 1 billion doses a year, beginning 2021.
By: Reuters |
Published: July 27, 2020 8:47:35 pm
In this handout photo released by the University of Oxford a doctor takes blood samples for use in a coronavirus vaccine trial in Oxford, England, Thursday June 25, 2020. (John Cairns, University of Oxford via AP)Moderna Inc said on Monday it had started a late-stage trial to test the effectiveness of its COVID-19 vaccine candidate, the first such study under the Trump administration’s program to speed development of measures against the novel…
Continue Reading